Global child deaths from pneumonia have been cut in half since 2009
Childhood pneumonia deaths have been cut roughly in half since 2009, when a new kind of vaccine funding model launched and 438 million children across 64 countries received pneumococcal vaccines. The breakthrough wasn’t just the science — it was a $1.5 billion fund that guaranteed manufacturers a buyer, bringing prices down so lower-income countries could finally afford to protect their kids. In Kenya, invasive pneumococcal disease in young children dropped 92% within eight years of rollout. Now the vaccine is reaching fragile places like Chad, Somalia, and South Sudan, where a single dose can mean the difference between life and death. It’s a quiet reminder that when global health gets the funding right, millions of children grow up who otherwise wouldn’t.








